(Total Views: 94)
Posted On: 07/08/2017 8:16:52 PM
Post# of 23071
Re: OldSaltDawg #18103
$PRTK -- This is on the biopharm post I made earlier. Check out the stock chart,,,apparently good news is expected this week as the last 50 minutes of trading on Friday had three gaps up,,,from $23.35 to $23.85 HOWEVER,,,it did drop $.35 in after- hour trading. I plan to wait to see what happens until 10:15 - 10:30 am before I make up my mind.
PRTK
Omadacycline - oral
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 Phase 3 completion of enrollment announced May 8, 2017. Data due mid-July 2017. July 15 estimate based on company guidance of "mid-July".
PRTK
Omadacycline - oral
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 Phase 3 completion of enrollment announced May 8, 2017. Data due mid-July 2017. July 15 estimate based on company guidance of "mid-July".
(1)
(0)
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'
https://twitter.com/twitter/statuses/957208055766241280
https://twitter.com/twitter/statuses/957208055766241280
